Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antenatal Myo-inositol Supplementation in Pre-existing Diabetes to Promote Normal Neonatal Outcomes

NCT07241221 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT07241221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antenatal Myo-inositol Supplementation in Pre-existing Diabetes to Promote Normal Neonatal Outcomes
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Recruiting
Start date
December 31, 2025
Completion date
August 31, 2029
Enrollment
182 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

perinatal and neonatal outcomes in pregnancies with type 2 diabetes mellitus (t2dm)